Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib/II Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)

NCT02423954 is registered in ClinicalTrials.gov with Western Regional Medical Center as lead sponsor.

NCT NCT02423954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02423954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib/II Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)
Lead sponsor
Western Regional Medical Center
Phase
Phase 1/2
Overall status
Terminated
Start date
April 30, 2015
Completion date
November 1, 2017
Enrollment
33 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, colorectal carcinoma, endometrial, non small cell lung cancer, pancreatic cancer, renal cell cancer, uterine